Strive CEO Says ASST Can Outrun Strategy in the Next Bitcoin Bull Market

Cryptopotato2026/10/05 22:15

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Strive CEO Matt Cole is pitching his company as the likeliest “fastest horse” among Bitcoin treasury firms in the next bull market, and he backed it with seven principles on competition posted on X.

His broader argument, however, is that Strive and Strategy need each other to expand the market for Bitcoin-backed digital credit rather than simply fight for the same investors.

Strive Claims Twice Strategy’s Amplification

“I think Strive has emerged as the leading contender to be the fastest horse in the next bull market,” Cole told Podcaster Robin Seyr. “What will drive the highest total returns will be one, having a high amplification ratio; two, being able to maintain a high amplification ratio; and three, not giving up Bitcoin upside for that amplification ratio.”

Amplification compares a company’s preferred stock and debt with the value of its Bitcoin. Strive’s own tracker puts its ratio at 51.4%, all of it from SATA preferred shares, with no debt, while Strategy’s is roughly 25%, putting Cole’s firm at about twice the amplification of Michael Saylor’s.

According to him, the next bull run could see Bitcoin go anywhere from $400,000 to $500,000 by late 2029, tied to a US debt crisis that pushes long-term yields down and weakens the dollar, and he described that as conservative.

The Strive chief was equally keen to play down any feud with Saylor’s company, pointing to a long article in which Strategy’s co-founder pictured the two firms working together.

SATA trades at between 25% and 50% of STRC’s daily volume, he noted, which some Strategy investors read as lost market share, but he called that “a really bad argument,” considering that had Strategy captured all of SATA’s roughly $1 billion, STRC would be only about 10% bigger. According to Cole, what matters more is whether the pool of digital credit can grow exponentially over the next three and a half years.

Institutions face issuer limits, he added, so large buyers need several issuers. He also claimed each firm has copied the other, citing Strategy’s move to daily dividends and its cash reserve.

“I’m glad that they innovate based on what we do and we innovate based on what they do,” he told Seyr.

Strive Holds 29,462 BTC to Strategy’s 848,000

As CryptoPotato reported earlier, Strive bought 2,000 BTC for $169 million on October 5, the same day Strategy announced 334 BTC for $28.7 million. That leaves Strive with 29,462 BTC and Strategy with 848,000.

ASST was trading near $30 at the time of writing, up about 137% in three months and down about 42% over a year. Meanwhile, SATA is paying a 13% dividend daily, against 12% on Strategy’s STRC.

Tags:

Bitcoin Bull Run MicroStrategy Strive

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

October 7th - ** Shares of memory chip manufacturer Micron (MU.O) fell 2.8% in pre-market trading to $1,016.26 ** The Taiwan labor union representing Micron Technology employees has won approval for a strike over the bonus plan (link). ** With the memory chip market already facing tight supply, the strike could intensify market concerns over supply ** “The union is aware that memory prices have surged and Micron is generating huge revenues. This gives employees more bargaining power, and investors now need to factor this in,” said Kathleen Brooks, Research Director at XTB ** Shares of other US chipmakers also declined, with Nvidia (NVDA.O), Advanced Micro Devices (AMD.O), and Broadcom (AVGO.O) down 0.68%, 1.95%, and 1.02% respectively ** US-listed shares of contract chip manufacturer TSMC (TSM.N) fell 2.05%, while smartphone chipmaker Qualcomm (QCOM.O) dropped 1.40% ** By the close of the previous trading day, MU’s share price had risen nearly fourfold so far this year, while the Philadelphia Semiconductor Index (.SOX) had gained over 86% (For non-English speakers’ convenience, Reuters provides automated translations of its reports into several other languages. Automated translations may contain errors or lack necessary context; Reuters does not guarantee the accuracy of these translations and provides them solely for reader convenience. Reuters accepts no liability for any harm or loss due to use of the automated translation function.)

路透社•2026/10/07 13:11

Evernorth Will Implement Active Measures to Increase XRP’s Value

TimesTabloid•2026/10/07 13:09

Indian Rupee: Gradual tightening path after RBI hike – ING

FXStreet•2026/10/07 13:06

BUZZ – Lipocine shares soar after Canada approves its testosterone replacement therapy

October 7 - ** Pharmaceutical company Lipocine (LPCN.O) saw its stock price rise 28% in pre-market trading to $2.7. ** Lipocine announced that (link) it has received approval from Health Canada for its oral testosterone replacement therapy drug, Tlando, for the treatment of male hypogonadism. ** In January 2024, Lipocine licensed the commercialization rights for Tlando in the US and Canada to the private company Verity Pharma. ** Lipocine is eligible to receive milestone payments of up to $259 million, as well as royalties ranging from 12% to 18% based on Tlando’s net sales. ** According to Lipocine, over 700,000 prescriptions for testosterone replacement therapy (TRT) are issued annually in Canada, with approximately 50% of patients reimbursed through private insurance. ** TRT is available in multiple formulations, including injections, oral medications, and topical gels. ** As of the previous trading session’s close, LPCN shares had declined by 73% year-to-date. (For the convenience of non-English speakers, Reuters automatically translates its reports into several other languages. Since automatic translations may be inaccurate or lack desired context, Reuters does not guarantee the accuracy of translated content and provides such translations for user convenience only. Reuters accepts no responsibility for any harm or loss resulting from the use of automated translation features.)

路透社•2026/10/07 12:56